Member Info for PL75

Gordon, I think you’ve met one of your own kind, a quick scan at zebbo’s posting history and he was saying that we were cheap as chips at 150p. Suddenly there’s doom and gloom everywhere. Weird huh?

‘I just hope the tests ready soon as a second wave seems coming soon would not want to miss out again!’

MFM, we’re nowhere near finished with the first wave yet, and have a gander at the states who reopened too soon:

https://twitter.com/TetotRemi/status/1271401589115367424

Everyone should pay heed to Gordon Chengkko’s warning. Really looking forward to it, but I expect nothing related to the presentation to be announced as I expected nothing last week. My view; ups and down until the prototype, then a jump, then more wild ups and downs as we wait for the results of validation - squeaky bum time.

Out of everything we might get a BAMS update out of the blue, remember that ol’ thing that could be the gold standard?

Quite the childish drama queen, methinks.

Inflated? Uproar? and No, I’m not telling you?

I just pictured an angry toddler stamping their feet.

You didn’t state it was interesting, you stated it as a fact and what’s with your obsession with winding necks?

Obviously not. Anyone else got any facts that then just become something interesting when challenged?

Here’s one then, the LFT will contain a hologram of Sir Al that’ll pop up like Princess Leia and will gargle ‘help me Awacta, you’re my only hope’ as you spit on it

And personally I don’t give a crap about unsubstantiated claims, if I did that I’d believe tkevin who suggested that Awacta don’t know anything about diagnostics.

You’re hardly setting the world alight by saying, with no evidence, the test will be linked to an app. The govt want an app, we will hopefully have a 10 min test, the govt know about our test. Could they be linked at some point? Not sure Captain Obvious.

Oh, ok. A first time poster with insider knowledge. Marvellous. Have a read of the FCA warning for starters.

It’s not that I don’t believe you, it’s an obvious thing to do, but I rely on RNS announcements, call me old fashioned.

Who said that? When? Show me?

I’ve previously shown my workings an Awacta having $2Bn in the bank (£8) on conservative calcs, plus other value, which gets you to a tenner quite easily. I disagree about using a PE ratio as they won’t be recurring profits.

This weekend’s crew are a bit odd. Sweeping generalisations on who bought when and why, not to mention the clown who is suggesting Awacta don’t know anything about diagnostics despite there being a diagnostics division.

The Awacta bulletin board, the place that never ceases to amaze me.

I’ll restate my figures, first bought in thanks to a tip on Shares mag, average about a quid currently. I was here for the Covid fast buck and if I feel it’s overshooting I might take it. My targets would be about a fiver once the test is out there, about a tenner once the full commercial landscape becomes clearer and then after that, I couldn’t say as we’re in a different position then. We’d be a very cash rich business with a huge amount of cash to start to crack the $100Bn antibody market. This is why I might just become a long term holder.

Or 50p if it doesn’t work, for balance, but will recover quickly above my average (which is all that matters of course) thanks to putting the £48m to work.

Perfect place to ask, no one has a clue, Sir Al isn’t giving away any commercial details as he’s still negotiating with other companies. The only route to market we know of is DTC via medusa

Sir Al has already said that demand will exceed the manufacturing capability of Cytiva and conversations with other manufacturers are already happening. The second we (hopefully) have a validated test that’s good enough, the contracts will be signed and production will start. Sona are irrelevant to that, no offence to any fans

Yes then. 100m per year versus likely demand of several hundred million per month. Don’t worry, Awacta can step in with their easy to manufacture affimers

The purpose of the vaccine is to break the transmission chain. That can also be achieved by identifying anyone that has it via an LFD and isolating them. Add me to the list of people that are not anti-vax and don’t want to have a rushed vaccine.

(For ipad autocorrect fans, that said anti-fax until I spotted it. I’m definitely not anti-fax too, but I’m pretty sure my love for obsolete technology might have undermined my post)

*changer

A genuine life change for people, that’s the long term project I was talking about. Potentially good returns from it, but similar to the oncology work here, it’s as much about the impact on people that’s amazing

Just watched GDRs presentation. Very similar story, a good presentation, he then said no sales update for a month and I see the price has taken a hit. I was impressed though, they’ve got a product ready to go to market and sales this month. They’ve also got other projects for later in the year that could cover their market cap. I’m not sure I’d be a long term holder, but it’s payday next week and if their share price is still where it is now I think I’ll chuck some cash in for a short term trade. Obviously with all profits coming back to our superior product here :o)

I’ve just been lurking and their board is the same as ours was yesterday, littered with deramping trading scum. Just in case you’re wondering why it’s peaceful...

Medusa ramping up (agree, can't see that one happening)
New manufacturing partners (they're talking now, but I can't see pen being put to paper until the strip is approved, I think we'll get an absolute monster RNS)
New "different type of test" partners (Maybe....)
BAMS test approval (Maybe...)
Affirmer blocking tech partner (can't remember the post, did someone say we might have more homework to do first?)
I'll add... Deals with the BAMS companies (again, this will come on the same day it's all approved and ready to go)

Don’t underestimate Awax’s post, Sir Al couldn’t divulge full details but there will no no delay in getting the product to market due to a lack of investment by medusa. Which is nice.